Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Detection and Quantification of Carbohydrate-Deficient Transferrin by MALDI-Compatible Protein Chips Prepared by Ambient Ion Soft Landing

P. Darebna, J. Spicka, R. Kucera, O. Topolcan, E. Navratilova, V. Ruzicka, M. Volny, P. Novak, P. Pompach,

. 2018 ; 64 (9) : 1319-1326. [pub] 20180712

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK ProQuest Central from 2002-12-01 to 2022-04-30
Open Access Digital Library from 1955-02-01
Medline Complete (EBSCOhost) from 2010-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest) from 2002-12-01 to 2022-04-30
Health & Medicine (ProQuest) from 2002-12-01 to 2022-04-30
Public Health Database (ProQuest) from 2002-12-01 to 2022-04-30

BACKGROUND: Transferrin is synthetized in the liver and is the most important iron-transport carrier in the human body. Severe alcohol consumption leads to alterations in glycosylation of transferrin. Mass spectrometry can provide fast detection and quantification of transferrin isoforms because they have different molecular masses. In this study, we used antibody chips in combination with MALDI-TOF MS for the detection and quantification of transferrin isoforms. METHODS: Protein chips were prepared by functionalization of indium tin oxide glass using ambient ion soft landing of electrosprayed antitransferrin antibody. Two microliters of patient serum was applied on the antibody-modified spots, and after incubation, washing, and matrix deposition, transferrin isoforms were detected by MALDI-TOF MS. Peak intensities of each transferrin form were used to calculate total carbohydrate-deficient transferrin (CDT). The CDT values obtained by the MALDI chip method were compared with the results obtained by a standard capillary electrophoresis (CE). RESULTS: The chip-based MALDI-TOF MS method was used for enrichment and detection of CDT from human serum. A sample cohort from 186 patients was analyzed. Of these samples, 44 were positively identified as belonging to alcoholic patients, whereas 142 were negative by the MALDI chip approach. The correlation of the data obtained by the CE and the chip-based MALDI was r = 0.986, 95% CI. CONCLUSIONS: Functionalized MALDI chips modified by antitransferrin antibody prepared by ambient ion soft landing were successfully used for detection and quantification of CDT from human sera.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045373
003      
CZ-PrNML
005      
20200113134900.0
007      
ta
008      
200109s2018 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1373/clinchem.2017.285452 $2 doi
035    __
$a (PubMed)30002097
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Darebna, Petra $u Institute of Microbiology, v.v.i., Czech Academy of Sciences, Prague, Czech Republic. Faculty of Science, Charles University, Prague, Czech Republic.
245    10
$a Detection and Quantification of Carbohydrate-Deficient Transferrin by MALDI-Compatible Protein Chips Prepared by Ambient Ion Soft Landing / $c P. Darebna, J. Spicka, R. Kucera, O. Topolcan, E. Navratilova, V. Ruzicka, M. Volny, P. Novak, P. Pompach,
520    9_
$a BACKGROUND: Transferrin is synthetized in the liver and is the most important iron-transport carrier in the human body. Severe alcohol consumption leads to alterations in glycosylation of transferrin. Mass spectrometry can provide fast detection and quantification of transferrin isoforms because they have different molecular masses. In this study, we used antibody chips in combination with MALDI-TOF MS for the detection and quantification of transferrin isoforms. METHODS: Protein chips were prepared by functionalization of indium tin oxide glass using ambient ion soft landing of electrosprayed antitransferrin antibody. Two microliters of patient serum was applied on the antibody-modified spots, and after incubation, washing, and matrix deposition, transferrin isoforms were detected by MALDI-TOF MS. Peak intensities of each transferrin form were used to calculate total carbohydrate-deficient transferrin (CDT). The CDT values obtained by the MALDI chip method were compared with the results obtained by a standard capillary electrophoresis (CE). RESULTS: The chip-based MALDI-TOF MS method was used for enrichment and detection of CDT from human serum. A sample cohort from 186 patients was analyzed. Of these samples, 44 were positively identified as belonging to alcoholic patients, whereas 142 were negative by the MALDI chip approach. The correlation of the data obtained by the CE and the chip-based MALDI was r = 0.986, 95% CI. CONCLUSIONS: Functionalized MALDI chips modified by antitransferrin antibody prepared by ambient ion soft landing were successfully used for detection and quantification of CDT from human sera.
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a lidé $7 D006801
650    _2
$a referenční standardy $7 D012015
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a spektrometrie hmotnostní - ionizace laserem za účasti matrice $x přístrojové vybavení $7 D019032
650    _2
$a transferin $x analogy a deriváty $x metabolismus $x normy $7 D014168
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Spicka, Jan $u Department of Laboratory Diagnostics, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
700    1_
$a Kucera, Radek $u Department of Immunochemistry, University Hospital in Pilsen, Pilsen, Czech Republic.
700    1_
$a Topolcan, Ondrej $u Department of Immunochemistry, University Hospital in Pilsen, Pilsen, Czech Republic.
700    1_
$a Navratilova, Eva $u Psychiatric Hospital in Dobrany, Dobrany, Czech Republic.
700    1_
$a Ruzicka, Viktor $u BioVendor, Karasek, Brno, Czech Republic.
700    1_
$a Volny, Michael $u Institute of Microbiology, v.v.i., Czech Academy of Sciences, Prague, Czech Republic. AffiPro, s.r.o., Mratin, Czech Republic.
700    1_
$a Novak, Petr $u Institute of Microbiology, v.v.i., Czech Academy of Sciences, Prague, Czech Republic. Faculty of Science, Charles University, Prague, Czech Republic. AffiPro, s.r.o., Mratin, Czech Republic.
700    1_
$a Pompach, Petr $u Institute of Microbiology, v.v.i., Czech Academy of Sciences, Prague, Czech Republic; pompach@biomed.cas.cz. Faculty of Science, Charles University, Prague, Czech Republic. AffiPro, s.r.o., Mratin, Czech Republic.
773    0_
$w MED00001129 $t Clinical chemistry $x 1530-8561 $g Roč. 64, č. 9 (2018), s. 1319-1326
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30002097 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113135232 $b ABA008
999    __
$a ok $b bmc $g 1483642 $s 1084046
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 64 $c 9 $d 1319-1326 $e 20180712 $i 1530-8561 $m Clinical chemistry $n Clin Chem $x MED00001129
LZP    __
$a Pubmed-20200109

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...